Efficacy of olopatadine hydrochloride 0.1%, emedastine difumarate 0.05%, and loteprednol etabonate 0.5% for Chinese children with seasonal allergic conjunctivitis: a randomized vehicle-controlled study

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

(2014) Eugene B. McLaurin et al.   ADVANCES IN THERAPY

Sensitization to Asian dust and allergic rhinoconjunctivitis

(2014) Tatsuya Mimura et al.   ENVIRONMENTAL RESEARCH

Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis

(2014) B. Mortemousque et al.   JOURNAL FRANCAIS D OPHTALMOLOGIE

Comparative Evaluation of Olopatadine 0.01% Combined Fluorometholone 0.1% Treatment Versus Olopatadine 0.01% Combined Ketorolac 0.4% Treatment in Patients with Acute Seasonal Allergic Conjunctivitis

(2013) Tuba Celik et al.   CURRENT EYE RESEARCH

Effects of Airborne Birch Pollen Levels on Clinical Symptoms of Seasonal Allergic Rhinoconjunctivitis

(2013) Denis Caillaud et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Effectiveness of Nonpharmacologic Treatments for Acute Seasonal Allergic Conjunctivitis

(2013) Paramdeep S. Bilkhu et al.   OPHTHALMOLOGY

Pollen aero allergens and the climate in mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients

(2013) Reginald M. Gorczynski   MEDICAL SCIENCE MONITOR

Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface

(2012) A. Leonardi et al.   ALLERGY

Loteprednol Etabonate Suspension 0.2% Administered QID Compared With Olopatadine Solution 0.1% Administered BID in the Treatment of Seasonal Allergic Conjunctivitis: A Multicenter, Randomized, Investigator-Masked, Parallel Group Study in Chinese Patients

(2012) Lan Gong et al.   CLINICAL THERAPEUTICS

Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: Early evidence supporting a paradigm shift in drug investigation?

(2012) Jonathan A. Bernstein   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes

(2012) Robert L. Jacobs et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pre-seasonal Treatment With Topical Olopatadine Suppresses the Clinical Symptoms of Seasonal Allergic Conjunctivitis

(2011) Masahiko Shimura et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Epidemiology of allergic conjunctivitis

(2011) Nelson Rosario et al.   Current Opinion in Allergy and Clinical Immunology

Ocular Allergy

(2011) Leonard Bielory   MOUNT SINAI JOURNAL OF MEDICINE

Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis

(2010) Brett P Bielory et al.   Current Opinion in Allergy and Clinical Immunology

Relationship between myopia and allergen-specific serum IgE levels in patients with allergic conjunctivitis

(2009) Tatsuya Mimura et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Seasonal and perennial allergic conjunctivitis: the possible role of nasal allergy

(2009) Zdenek Pelikan   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial

(2008) Mehmet Borazan et al.   ACTA OPHTHALMOLOGICA

Allergic Conjunctivitis

(2008) Leonard Bielory et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Ocular Allergy Overview

(2008) Leonard Bielory   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA